Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APDNNASDAQ:AUUDNASDAQ:DKDCANASDAQ:LYT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPDNApplied DNA Sciences$0.38-26.9%$1.04$0.38▼$177.00$417K0.41446,849 shs1.76 million shsAUUDAuddia$4.14-1.4%$4.06$2.88▼$31.62$2.11M0.892,810 shs5,465 shsDKDCAData Knights Acquisition$0.41+0.5%$0.46$5.00▼$13.51$2.13M0.1839,705 shs343,876 shsLYTLytus Technologies Holdings PTV.$0.07-40.6%$0.07$0.05▼$3.20$2.18M2.210.95 million shs49.56 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPDNApplied DNA Sciences-1.84%-10.89%-39.98%-92.75%-98.28%AUUDAuddia-1.87%+2.44%+26.51%-17.95%-80.85%DKDCAData Knights Acquisition+0.49%+1.11%+7.31%-58.90%-79.55%LYTLytus Technologies Holdings PTV.0.00%0.00%0.00%-60.40%-97.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPDNApplied DNA Sciences1.4606 of 5 stars3.52.00.00.02.30.00.0AUUDAuddia0.4709 of 5 stars0.04.00.00.02.50.00.0DKDCAData Knights AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ALYTLytus Technologies Holdings PTV.N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPDNApplied DNA Sciences 3.00Buy$75.0019,741.27% UpsideAUUDAuddia 0.00N/AN/AN/ADKDCAData Knights Acquisition 0.00N/AN/AN/ALYTLytus Technologies Holdings PTV. 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPDNApplied DNA Sciences$3.79M0.11N/AN/A$0.29 per share1.30AUUDAuddiaN/AN/AN/AN/A$0.53 per shareN/ADKDCAData Knights AcquisitionN/AN/A$0.00 per share111.42($1.82) per shareN/ALYTLytus Technologies Holdings PTV.$23.72M0.09$0.23 per share0.30$10.23 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPDNApplied DNA Sciences-$6.99M-$35.85N/A∞N/A-228.12%-101.57%-62.43%8/6/2025 (Estimated)AUUDAuddia-$8.81M-$41.96N/A∞N/AN/A-243.38%-143.18%N/ADKDCAData Knights Acquisition$340K-$0.19N/A∞N/AN/AN/A-5.55%N/ALYTLytus Technologies Holdings PTV.$290KN/A0.00∞N/AN/AN/AN/AN/ALatest APDN, AUUD, LYT, and DKDCA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q2 2025APDNApplied DNA Sciences-$3.00-$15.35-$12.35-$15.35$1.19 million$0.98 million3/5/2025Q4 2024AUUDAuddiaN/A-$14.96N/A-$0.88N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPDNApplied DNA SciencesN/AN/AN/AN/AN/AAUUDAuddiaN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/ALYTLytus Technologies Holdings PTV.N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPDNApplied DNA SciencesN/A4.724.53AUUDAuddiaN/A7.847.84DKDCAData Knights AcquisitionN/AN/AN/ALYTLytus Technologies Holdings PTV.N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPDNApplied DNA Sciences22.22%AUUDAuddiaN/ADKDCAData Knights Acquisition35.35%LYTLytus Technologies Holdings PTV.0.41%Insider OwnershipCompanyInsider OwnershipAPDNApplied DNA Sciences0.17%AUUDAuddia7.61%DKDCAData Knights Acquisition45.72%LYTLytus Technologies Holdings PTV.84.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPDNApplied DNA Sciences701.10 million55.10 millionOptionableAUUDAuddia20510,0005.52 millionNot OptionableDKDCAData Knights Acquisition25.17 million2.81 millionNot OptionableLYTLytus Technologies Holdings PTV.331.11 million3.57 millionNot OptionableAPDN, AUUD, LYT, and DKDCA HeadlinesRecent News About These CompaniesLytus Technologies Holdings PTV. (NASDAQ:LYT) & Bilibili (NASDAQ:BILI) Critical ReviewMay 28 at 1:17 AM | americanbankingnews.comLytus Technologies Expands Share Capital to 5 BillionMay 27 at 4:37 PM | tipranks.comLytus Technologies Amplifies Growth with OTC Market Entry and Strategic ExpansionApril 1, 2025 | devdiscourse.comLytus Technologies Adjusts Market Strategy and Transition to OTC MarketsMarch 31, 2025 | finance.yahoo.comLytus Technologies announces 24% Revenue Growth for H1 FY2025March 17, 2025 | globenewswire.comLytus Technologies Secures Second Tranche of $1 Million AdvanceMarch 17, 2025 | tipranks.comLytus Technologies announces 24% Revenue Growth for H1 FY2025March 17, 2025 | theprint.inLytus Technologies Reports Robust Financial Growth Amidst ExpansionsMarch 17, 2025 | devdiscourse.comLytus Technologies Stock Hits 52-Week Low at $0.24 Amid Steep DeclineFebruary 12, 2025 | msn.comLytus Technologies Expands HealthTech Initiatives and Strengthens Growth TrajectoryFebruary 6, 2025 | globenewswire.comLytus Technologies Holdings PTV. Ltd. (LYT) Launches Lytus HealthTech to Enhance Healthcare Accessibility with AI-Driven SolutionsJanuary 30, 2025 | insidermonkey.comLytus Technologies launches healthtech subsidiaryJanuary 29, 2025 | msn.comLytus Technologies Expands Its Footprint into Healthcare with Cutting-Edge Patient-Centric HealthTech PlatformJanuary 28, 2025 | globenewswire.comLytus Technologies stock hits 52-week low at $0.61January 16, 2025 | msn.comLYT Stock Fluctuations: The Real StoryDecember 26, 2024 | bovnews.comNASDAQ-Listed LYTUS Appoints Visionary Leader Sai Guna Ranjan Puranam as COO (Lytus Healthcare) and Group CTO (Lytus Technologies)December 18, 2024 | news.webindia123.comPureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual MeetingDecember 9, 2024 | businesswire.comWhy Is Lytus Technologies (LYT) Stock Up 109% Today?August 6, 2024 | investorplace.comLytus Technologies enters the audio entertainment sector with the launch of Radio Room, India's first regional Audio OTT platformJune 20, 2024 | globenewswire.comJoin Lytus Technologies' Exclusive Live Investor Webinar and Q&A Session on March 27March 22, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAPDN, AUUD, LYT, and DKDCA Company DescriptionsApplied DNA Sciences NASDAQ:APDN$0.38 -0.14 (-26.90%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Auddia NASDAQ:AUUD$4.14 -0.06 (-1.43%) As of 12:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Auddia Inc., a technology company, develops AI Platform for the audio and podcast markets. The company's flagship product is faidr, which enables consumers to listen to various AM/FM radio station with commercial breaks replaced with personalized audio content, including popular and new music, news, and weather. It also provides Vodacast mobile app, an interactive differentiated podcasting that allows podcasters to give their audiences an interactive audio experience; and Podcast Hub, a content management system. The company was formerly known as Clip Interactive, LLC and changed its name to Auddia Inc. in November 2019. Auddia Inc. was founded in 2012 and is headquartered in Boulder, Colorado.Data Knights Acquisition NASDAQ:DKDCA$0.41 +0.00 (+0.49%) As of 05/27/2025Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.Lytus Technologies Holdings PTV. NASDAQ:LYT$0.07 -0.05 (-40.59%) Closing price 03/28/2025Extended Trading$0.07 0.00 (0.00%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lytus Technologies Holdings PTV. Ltd. operates as a platform services company in India. The company engages in the distribution of linear content streaming/telecasting services; and development of telemedicine products. Lytus Technologies Holdings PTV. Ltd. was incorporated in 2020 and is based in Dubai, the United Arab Emirates. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? CrowdStrike Stock Slips: Analyst Downgrades Before Earnings AutoZone Stock to Cross $4400 This Year: This Is Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
